Telomere shortening may contribute to the limited lifespan of somatic
cells and telomerase, the enzyme that elongates telomeric DNA and main
tains telomere length, may be essential for unlimited cell proliferati
on irt vivo and in vitro. Telomerase is not expressed in most human so
matic cells but is a nearly ubiquitous tumour marker, being activated
in malignant cells from many cancers, Inhibition of telomerase may lea
d to telomere shortening and eventually limit the proliferative capaci
ty of malignant cells and hence be of therapeutic value, With the inte
nt of characterizing an animal model for inhibition studies, we invest
igated telomerase activity during mammary tumorigenesis in transgenic
mice overexpressing the neu gene, We detected activity in primary mamm
ary tumours and lung metastases but also in normal mammary glands and
other organs, Activity Tvas elevated in tumors versus normal tissues a
nd was enhanced by short-term culturing of normal cells, Telomerase ac
tivity was also present in somatic tissues from the non-transgenic par
ental strain and the outbred Mus spretus strain, As we recently detect
ed telomerase activity in normal human hemopoietic tissues, mouse mode
ls of tumorigenesis may provide useful experimental systems for assess
ing the outcome of in vivo inhibition of telomerase in both malignant
and normal cells.